| 000 | 01692 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513151117.0 | ||
| 264 | 0 | _c19981030 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWendling, D | |
| 245 | 0 | 0 |
_aA randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cAug 1998 |
||
| 300 |
_a1457-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xmetabolism |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aCD4 Antigens _ximmunology |
| 650 | 0 | 4 |
_aCD4 Lymphocyte Count _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 | _aImmunoglobulins, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRacadot, E | |
| 700 | 1 | _aWijdenes, J | |
| 700 | 1 | _aSibilia, J | |
| 700 | 1 | _aFlipo, R M | |
| 700 | 1 | _aCantagrel, A | |
| 700 | 1 | _aMiossec, P | |
| 700 | 1 | _aEschard, J P | |
| 700 | 1 | _aMacro, M | |
| 700 | 1 | _aBertin, P | |
| 700 | 1 | _aLioté, F | |
| 700 | 1 | _aDebiais, F | |
| 700 | 1 | _aJuvin, R | |
| 700 | 1 | _aLe Goff, P | |
| 700 | 1 | _aMasson, C | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 25 _gno. 8 _gp. 1457-61 |
|
| 999 |
_c9677666 _d9677666 |
||